Trial Profile

Open randomised study for evaluation of an active hepatitis B vaccination (HBvaxPRO) in combination with a passive immunisation with hepatitis B immunoglobulins (Hepatect) for subjects who did not show any or an adequate reaction to a previous sole active hepatitis B immunisation.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Dec 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hepatitis B immune globulin (Primary) ; Hepatitis B vaccine recombinant (HBvaxPro) (Primary)
Indications Hepatitis B
Focus Pharmacodynamics
Acronyms PAI-Study

12 Apr 2012 Actual initiation date changed from 1 Aug 2008 to 2 Apr 2008 as reported as reported by European Clinical Trials Database.
23 Oct 2008 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com